Quick Overview Availability: In Stock Ibrance is usually prescribed in combination with letrozole (Femara) or fulvestrant (Faslodex) for the treatment of HR-positive, HER2-negative breast cancer in postmenopausal women. It has been clinically proven to extend progression-free survival, improve response rates, and help patients maintain a better quality of life during cancer therapy.  For Help, Call Now - 0300-2500997 Size - 21 Tablets Item Form - Tablets Imported From - USA